Teleflex (NYSE:TFX) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. In the table below, you'll find a summary of their recent ratings, ...

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Teleflex (NYSE:TFX) in the last three months. The table below provides a snapshot of their ...

As of Thursday, February 26, Teleflex Incorporated’s TFX share price has surged by 7.09%, which has investors questioning if this is right time to sell.

What Happened? A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected ...

Medical technology company Teleflex (NYSE:TFX) missed Wall Street’s revenue expectations in Q4 CY2025, with sales falling 28.5% year on year to $569 million. Its non-GAAP profit of $1.93 per share was ...

Teleflex Incorporated TFX posted fourth-quarter 2025 adjusted earnings per share (EPS) from continuing operations of $1.93, up 1% from the year-ago quarter’s figure. The metric missed the Zacks ...

Medical technology company Teleflex (NYSE:TFX) will be reporting results tomorrow before market hours. Here’s what to expect.

Teleflex ( (TFX)) has issued an update. Teleflex Incorporated reported a 2.4% increase in GAAP revenue for Q3 2024, reaching $764.4 million, with strong contributions from Interventional and Vascular ...

Investing.com - Needham raised its price target on Teleflex Inc. shares (NYSE:TFX) to $147 from $138 while maintaining a Buy rating on the stock. The shares currently trade at $119.63, and ...